Publications by authors named "Marketa Hanustiakova"
Article Synopsis
- * It was found that after two doses of the Pfizer/BioNTech mRNA vaccine, those treated with the original drug maintained stable antibody levels, whereas those on the biosimilar showed a significant decrease in antibody levels over time.
- * A strong statistical difference was observed in SARS-CoV-2 antibody levels between patients receiving biological treatment (both original and biosimilar) and those not receiving any biological treatment, indicating that the type of treatment rather than other factors like age
